Tag: FY2023
ONWARD® Medical: Announces FY2023 Results and Shares FY2024 Highlights to Date. – 04/26/2024 at 6:30 p.m.
– Submission to the FDA of a request for classification of the ARC-EX® System device based on risks (“De Novo” request) – Fundraising of 20 million euros – Announcement of…